BP vs EE
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
BP's Advanced Deterministic Scorecard shows a Piotroski F-Score of 6/9, indicating stable financial health, but the absence of an Altman Z-Score limits distress risk assessment. The stock trades at a significant premium to its Graham Number ($7.35) and even the growth-based intrinsic value ($18.88), currently priced at $36.53, driven by high forward earnings expectations. While profitability metrics and dividend yield are attractive, elevated valuation multiples, inconsistent earnings surprises, and a dangerously high payout ratio of 315% raise sustainability concerns. Analysts recommend a 'buy' with a target of $38.73, supported by strong insider sentiment, though no insider transactions have occurred recently.
Excelerate Energy exhibits strong fundamental health with a Piotroski F-Score of 7/9 and a robust liquidity profile (Current Ratio 2.43). While the stock trades below its growth-based intrinsic value of $37.76, it sits above the defensive Graham Number of $24.77, suggesting a premium valuation. The company shows impressive operating margins and low debt relative to the energy sector, but this is offset by a recent trend of earnings misses (only 1 of the last 4 quarters beat estimates) and bearish insider sentiment. The divergence between strong balance sheet health and deteriorating short-term earnings momentum warrants a neutral stance.
Compare Another Pair
BP vs EE: Head-to-Head Comparison
This page compares BP p.l.c. (BP) and Excelerate Energy, Inc. (EE) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.